Skip to main content
. 2022 Apr 28;2(5):100132. doi: 10.1016/j.xjidi.2022.100132

Table 1.

Characteristics of Patients (n = 45) and Healthy Controls (n = 20)

Characteristics Patients Controls P-Value
n 45 20
Sex1 0.27972
 Male 29 (64.4) 10 (50.0)
 Female 16 (35.6) 10 (50.0)
Age (y)3 62.7 (17.5–83.4) 54.5 (24.4–79.1) 0.13932
Race/Ethnicity1 0.90412
 Asian 2 (4.4) 3 (15.0)
 Black 5 (11.1) 0 (0.0)
 White 30 (68.9) 15 (75.0)
White/Hispanic 6 (13.3) 1 (5.0)
Other/Hispanic 1 (2.2) 1 (5.0)
Phototype1 0.23982
 Light (FST I‒III) 45 (100.0) 19 (95.0)
 Dark (FST IV‒VI) 0 (0.0) 1 (5.0)
Comorbidities1
 HTN 20 (44.4) 6 (30.0) 0.4114
 DLP 24 (53.3) 7 (35.0) 0.1924
 GERD 11 (24.4) 6 (30.0) 0.7614
Diagnosis Subtype1
 MF 40 (88.9)
 SS 5 (11.1)
Clinical stage1
 Early (IA‒IIA) 26 (57.8)
 Advanced (IIB‒IVB) 19 (42.2)
Disease duration (y)3 3.1 (0.2–30.0)
mSWAT3 22 (3–100)

Abbreviations: DLP, dyslipidemia; FST, Fitzpatrick skin phototype; GERD, gastroesophageal reflux; HTN, hypertension; MF, mycosis fungoides; mSWAT, modified Severity Weighted Assessment Tool; SS, Sézary syndrome.

1

Data are presented as n (%).

2

Data were analyzed with two-tailed t-test.

3

Data are presented as median (range).

4

Data were analyzed with Fisher’s exact test.